SOLUTION
Cancer is a leading cause of death worldwide, accounting for an estimated 10 million deaths in 2020[7], or nearly one in six.
Whilst common in the developed world, what is less recognized and understood is the significant growth of cancer across the developing economies of the Global South.
A mere two decades or so ago, the percentage of new cases was similar across regions. Today, almost two-thirds of new cases arise in low- and middle-income nations and this could reach 70% by 2050.[8]
Treatment for cancer is expensive and access to affordable medicines and therapies is one of the key challenges that needs to be addressed. Jameel Health, together with our partners, is ready to play its part.
Footnotes
[7] WHO: https://www.who.int/news-room/fact-sheets/detail/cancer
[8] Harvard School of Public Health: https://www.hsph.harvard.edu/news/magazine/shadow-epidemic/
Featured Partner
Every day, people are diagnosed with life-changing conditions, but often cannot afford the medicines they need.
Through leveraging cutting-edge science and technology, and strategic partnerships with stakeholders from across the healthcare system, EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices; it aims to provide innovative, patent-protected medicines more efficiently and cost-effectively than ever before.
EQRx has already made significant progress toward their mission, starting with two potential therapies for the treatment of lung cancer. It now has a portfolio of over 10 programs.
In 2021, Jameel Health announced a partnership to become EQRx’s regulatory and commercial partner for aumolertinib and sugemalimab, if approved, in selected markets throughout the Middle East region, as well as in Türkiye and all of Africa. In late-2020, the JIMCO Life Sciences fund became an enthusiastic investor in EQRx and further increased our commitment in 2021.
Visit: EQRx
See All Partners
Other partners
Oncology Solutions
Resistance is not futile
For most of human history, even the tiniest of scratches could prove fatal. Never mind pneumonia, childbirth or surgery, gardening was a potentially deadly pursuit. A graze or scratch could become …
April 11, 2023 | Dubai, UAE
Forging a new model for cancer treatment: A Q&A with Professor R Charles Coombes
Forging a new model for cancer treatment: A Q&A with Professor R Charles Coombes, newly appointed special scientific advisor to Jameel Health.
April 11, 2023 | London, UK
Q&A Interview with Melanie Nallicheri, CEO EQRx & Akram Bouchenaki, CEO Jameel Health
Healthcare for the many; not only the few! A Q&A with Melanie Nallicheri, CEO of EQRx, on a mission to remake medicine.
February 7, 2022 | Dubai, UAE
Stethoscope of the Future
Jameel Health talks to Butterfly Network’s Dr. Peter Weimersheimer, about the truly innovative Butterfly iQ+
January 31, 2022 | Dubai, UAE
Democratizing healthcare scan by scan
Democratizing healthcare, scan by scan: Q&A with Butterfly Network & Jameel Health on their new distribution partnership for the innovative Butterfly iQ+ handheld imaging device.
November 25, 2021 | Dubai, UAE
Sharing a vision of a virtual future: Holoeyes & Jameel Health
Sharing a vision of a virtual future: Q&A with Holoeyes & Jameel Health on their new strategic collaboration on medical VR technology.
November 7, 2021 | Dubai, UAE
Cell mates – Q&A with CEO’s of Cellarity & Jameel Health
Cellarity is generating unprecedented biological insights by combining its unique expertise in network biology, high-resolution data &machine learning. The result is nothing short of revolutionary.
August 16, 2021 | Dubai, UAE
Progress through partnerships – Q&A with Prof. James J. Collins
Jameel Health is continually forging partnerships with leading organizations, researchers, innovators and thinkers in the global biotech and health industries. In 2021, it appointed Prof. James J. …
June 24, 2021 | Boston, USA
Accelerating access to healthcare for those who need it most
Healthcare – or rather adequate access to it – is one of the biggest challenges facing society today.
January 4, 2021 | Dubai, UAE
Putting healthcare at the heart of communities
Despite the unprecedented levels of global wealth created by economic development over the past century, millions of people across vast regions of our planet are dying unnecessarily through poor …
October 19, 2020 | Dubai, UAE
Accelerating access to health
The COVID-19 pandemic has been a stark reminder – if any were needed – of humankind’s persistent failure to address one of its most enduring, and potentially destabilizing, challenges – …
October 5, 2020 | Dubai, UAE
Investing in health-tech &digitizing healthcare
Health technology is transforming the way we can diagnose, treat and prevent disease, and has the potential to radically improve access to healthcare on a global scale.
September 22, 2020 | Dubai, UAE
Improving healthcare access in developing markets
From a longer-term historical perspective, the world we live in is undoubtedly fairer than it has ever been versus, say 100 years ago. In many – if not the majority – of countries across the …
September 10, 2020 | Dubai, UAE
New partnership with iSono Health
Jameel Health and iSono Health join forces to bring the world’s first AI-driven portable 3D breast ultrasound scanner to potentially help hundreds of millions of women in over 30 countries across …
January 30, 2023 | Dubai, UAE & South San Francisco, USA
Jameel Health appoints globally respected scientists as special scientific advisors.
Jameel Health appoints three globally respected scientists as special scientific advisors to join its mission in accelerating access to modern medical care across the global south.
July 5, 2022 | Dubai, UAE
Jameel Health and EQRx to introduce two affordable cancer treatments
Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey …
November 22, 2021 | Dubai, UAE
Jameel Health & Holoeyes Inc. announce strategic collaboration for 3D VR
Jameel Health & Holoeyes Inc. announce strategic collaboration bringing 3D virtual reality technology to Middle East, Africa & new sectors in Japan
November 2, 2021 | Tokyo, Japan
Our integrated solutions portfolio
- alj.com
- communityjameel.org
- For medical incidence reporting please email: safety@jameelhealth.com or call +971 4 448 0905
Download our News & Insights App
